Baker Bros. Advisors LP Prelude Therapeutics Inc Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
A detailed history of Baker Bros. Advisors LP transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,123,824 shares of PRLD stock, worth $37.8 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
10,123,824
Previous 10,123,824
-0.0%
Holding current value
$37.8 Million
Previous $43.2 Million
11.01%
% of portfolio
0.61%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
34.2MCall Options Held
200Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$40.7 Million1.16% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.13MShares$15.4 Million0.4% of portfolio
-
Boxer Capital, LLC San Diego, CA2.57MShares$9.58 Million0.63% of portfolio
-
Black Rock Inc. New York, NY1.1MShares$4.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.02MShares$3.79 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $136M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...